2021 Q1 Form 10-Q Financial Statement
#000156459021024996 Filed on May 06, 2021
Income Statement
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
Revenue | $97.73M | $96.07M |
YoY Change | 1.72% | 17.52% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $48.55M | $47.93M |
YoY Change | 1.3% | 20.32% |
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $2.891M | $2.871M |
YoY Change | 0.7% | 9.04% |
% of Gross Profit | ||
Operating Expenses | $48.55M | $47.93M |
YoY Change | 1.3% | 20.32% |
Operating Profit | ||
YoY Change | ||
Interest Expense | $7.135M | $10.16M |
YoY Change | -29.77% | 4.51% |
% of Operating Profit | ||
Other Income/Expense, Net | $8.262M | $9.819M |
YoY Change | -15.86% | 23.14% |
Pretax Income | $33.39M | -$9.850M |
YoY Change | -438.99% | -193.8% |
Income Tax | $7.869M | -$3.525M |
% Of Pretax Income | 23.57% | |
Net Earnings | $25.52M | -$6.325M |
YoY Change | -503.51% | -178.01% |
Net Earnings / Revenue | 26.11% | -6.58% |
Basic Earnings Per Share | $2.42 | -$0.58 |
Diluted Earnings Per Share | $2.31 | -$0.56 |
COMMON SHARES | ||
Basic Shares Outstanding | 10.54M | 10.90M |
Diluted Shares Outstanding | 11.07M | 11.25M |
Balance Sheet
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $7.200M | $14.70M |
YoY Change | -51.02% | 539.13% |
Cash & Equivalents | $86.24M | $69.32M |
Short-Term Investments | ||
Other Short-Term Assets | ||
YoY Change | ||
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $7.200M | $14.70M |
YoY Change | -51.02% | 539.13% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $40.70M | $15.16M |
YoY Change | 168.56% | 6.87% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $93.40M | $74.70M |
YoY Change | 25.03% | 92.03% |
Total Long-Term Assets | $1.091B | $1.064B |
YoY Change | 2.53% | 11.88% |
TOTAL ASSETS | ||
Total Short-Term Assets | $7.200M | $14.70M |
Total Long-Term Assets | $1.091B | $1.064B |
Total Assets | $1.098B | $1.079B |
YoY Change | 1.8% | 13.15% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $40.90M | $29.50M |
YoY Change | 38.64% | 68.57% |
Accrued Expenses | $29.70M | $28.80M |
YoY Change | 3.13% | 8.68% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $70.60M | $58.30M |
YoY Change | 21.1% | 32.5% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $744.0M | $769.3M |
YoY Change | -3.29% | 24.0% |
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $744.0M | $769.3M |
YoY Change | -3.29% | 24.0% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $70.60M | $58.30M |
Total Long-Term Liabilities | $744.0M | $769.3M |
Total Liabilities | $814.7M | $827.5M |
YoY Change | -1.55% | 24.32% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | $196.6M | |
YoY Change | -7.36% | |
Common Stock | $104.9M | |
YoY Change | 4.17% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | $50.07M | |
YoY Change | 99.93% | |
Treasury Stock Shares | $2.484K | |
Shareholders Equity | $283.6M | $251.4M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $1.098B | $1.079B |
YoY Change | 1.8% | 13.15% |
Cashflow Statement
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $25.52M | -$6.325M |
YoY Change | -503.51% | -178.01% |
Depreciation, Depletion And Amortization | $2.891M | $2.871M |
YoY Change | 0.7% | 9.04% |
Cash From Operating Activities | $35.01M | $44.56M |
YoY Change | -21.42% | 45.15% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $411.0K | $1.010M |
YoY Change | -59.31% | -23.19% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $9.100M | $1.300M |
YoY Change | 600.0% | -124.53% |
Cash From Investing Activities | $14.85M | $14.00K |
YoY Change | 105978.57% | -100.21% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | $11.83M | |
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -35.50M | -31.68M |
YoY Change | 12.06% | -3.41% |
NET CHANGE | ||
Cash From Operating Activities | 35.01M | 44.56M |
Cash From Investing Activities | 14.85M | 14.00K |
Cash From Financing Activities | -35.50M | -31.68M |
Net Change In Cash | 14.36M | 12.89M |
YoY Change | 11.42% | -244.95% |
FREE CASH FLOW | ||
Cash From Operating Activities | $35.01M | $44.56M |
Capital Expenditures | $411.0K | $1.010M |
Free Cash Flow | $34.60M | $43.55M |
YoY Change | -20.54% | 48.21% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y1M6D | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P4Y9M18D | |
CY2021Q1 | us-gaap |
Interest Expense
InterestExpense
|
7135000 | |
CY2020Q1 | us-gaap |
Interest Expense
InterestExpense
|
10159000 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
14000 | |
CY2021Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
11834000 | |
CY2021Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
1546000 | |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1563000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
25522000 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
283636000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
302783000 | |
CY2019Q4 | rm |
New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effects Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectsOfChangeOnEquityOrNetAssets1
|
-45922000 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
2000 | |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
25522000 | |
CY2020Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-6325000 | |
CY2021Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
11362000 | |
CY2021Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2891000 | |
CY2021Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-1000 | |
CY2020Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-19000 | |
CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1563000 | |
CY2020Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1419000 | |
CY2021Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
785000 | |
CY2020Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-29000 | |
CY2021Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-245000 | |
CY2020Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-5228000 | |
CY2021Q1 | rm |
Increase Decrease In Lease Assets
IncreaseDecreaseInLeaseAssets
|
536000 | |
CY2020Q1 | rm |
Increase Decrease In Lease Assets
IncreaseDecreaseInLeaseAssets
|
291000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-302000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-854000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1739000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1353000 | |
CY2021Q1 | rm |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
511000 | |
CY2020Q1 | rm |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
333000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
42325000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
44556000 | |
CY2021Q1 | us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
-9100000 | |
CY2020Q1 | us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
-1289000 | |
CY2021Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
769000 | |
CY2020Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
265000 | |
CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
411000 | |
CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1010000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
7920000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
14000 | |
CY2021Q1 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-129581000 | |
CY2020Q1 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-38684000 | |
CY2021Q1 | us-gaap |
Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
|
-5695000 | |
CY2021Q1 | us-gaap |
Insurance Services Revenue
InsuranceServicesRevenue
|
7985000 | |
CY2020Q1 | us-gaap |
Insurance Services Revenue
InsuranceServicesRevenue
|
5949000 | |
CY2021Q1 | us-gaap |
Other Income
OtherIncome
|
2467000 | |
CY2020Q1 | us-gaap |
Other Income
OtherIncome
|
3128000 | |
CY2021Q1 | us-gaap |
Revenues
Revenues
|
97731000 | |
CY2020Q1 | us-gaap |
Revenues
Revenues
|
96074000 | |
CY2021Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
11362000 | |
CY2020Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
49522000 | |
CY2021Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
28851000 | |
CY2020Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
29511000 | |
CY2021Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
6020000 | |
CY2020Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
5227000 | |
CY2021Q1 | us-gaap |
Marketing Expense
MarketingExpense
|
2710000 | |
CY2020Q1 | us-gaap |
Marketing Expense
MarketingExpense
|
1686000 | |
CY2021Q1 | us-gaap |
Other Expenses
OtherExpenses
|
8262000 | |
CY2020Q1 | us-gaap |
Other Expenses
OtherExpenses
|
9819000 | |
CY2021Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
45843000 | |
CY2020Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
46243000 | |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
33391000 | |
CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-9850000 | |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
7869000 | |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-3525000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
25522000 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6325000 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.42 | |
CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.58 | |
CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.31 | |
CY2020Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.56 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
10543000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
10897000 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
11066000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
11253000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
272123000 | |
CY2021Q1 | us-gaap |
Dividends Cash
DividendsCash
|
2206000 | |
CY2020Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
49522000 | |
CY2020Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2871000 | |
CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
7230000 | |
CY2020Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
9082000 | |
CY2020Q1 | us-gaap |
Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
|
8313000 | |
CY2021Q1 | us-gaap |
Proceeds From Repayments Of Accounts Receivable Securitization
ProceedsFromRepaymentsOfAccountsReceivableSecuritization
|
118567000 | |
CY2021Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
2506000 | |
CY2020Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
78000 | |
CY2021Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
2638000 | |
CY2020Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1231000 | |
CY2021Q1 | us-gaap |
Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
|
2196000 | |
CY2021Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
11834000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-35883000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-31680000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
14362000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
12890000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
71876000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
56427000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
86238000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
69317000 | |
CY2021Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
-199000 | |
CY2020Q4 | us-gaap |
Financing Receivable Percent Past Due1
FinancingReceivablePercentPastDue1
|
0.053 | |
CY2020Q4 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
1136259000 | |
CY2020Q4 | rm |
Finance Receivable Net Percent
FinanceReceivableNetPercent
|
1.000 | |
CY2020Q4 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
32239000 | |
CY2020Q4 | rm |
Financing Receivable Recorded Investment Nonaccrual Status Percent
FinancingReceivableRecordedInvestmentNonaccrualStatusPercent
|
0.028 | |
CY2021Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
2087000 | |
CY2020Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
2061000 | |
CY2021Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
2202000 | |
CY2020Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
2473000 | |
CY2021Q1 | us-gaap |
Cash
Cash
|
7226000 | |
CY2020Q4 | us-gaap |
Cash
Cash
|
8052000 | |
CY2020Q1 | us-gaap |
Cash
Cash
|
14668000 | |
CY2019Q4 | us-gaap |
Cash
Cash
|
2263000 | |
CY2021Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
79012000 | |
CY2020Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
63824000 | |
CY2020Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
54649000 | |
CY2019Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
54164000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
86238000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
71876000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
69317000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
56427000 | |
CY2021Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Note 1. Nature of Business </p> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Regional Management Corp. (the “<span style="text-decoration:underline;">Company</span>”) was incorporated and began operations in 1987. The Company is engaged in the consumer finance business, offering small loans, large loans, retail loans, and related payment and collateral protection insurance products. The Company previously offered automobile purchase loans, but ceased such originations in November 2017. As of March 31, 2021, the Company operated under the name “Regional Finance” in 365 branch locations across 11 states in the Southeastern, Southwestern, Mid-Atlantic, and Midwestern United States. </p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s loan volume and contractual delinquency follow seasonal trends. Demand for the Company’s small and large loans is typically highest during the second, third, and fourth quarters, which the Company believes is largely due to customers borrowing money for vacation, back-to-school, and holiday spending. Loan demand has generally been the lowest during the first quarter, which the Company believes is largely due to the timing of income tax refunds. Delinquencies generally reach their lowest point in the first half of the year and rise in the second half of the year. The current expected credit loss (“<span style="text-decoration:underline;">CECL</span>”) accounting model requires earlier recognition of credit losses compared to the prior incurred loss approach. This could result in larger allowance for credit loss releases in periods of portfolio liquidation, and larger provisions for credit losses in periods of portfolio growth compared to prior years. Consequently, the Company experiences seasonal fluctuations in its operating results. However, changes in borrower assistance programs and customer access to external economic stimulus measures related to the novel strain of coronavirus (“<span style="text-decoration:underline;">COVID-19</span>”) have impacted the Company’s typical seasonal trends for loan volume and delinquency. </p> | |
CY2021Q1 | us-gaap |
Number Of Stores
NumberOfStores
|
365 | |
CY2021Q1 | us-gaap |
Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
|
11 | |
CY2021Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Calibri;text-transform:none;font-variant: normal;">Use of estimates:<span style="font-weight:normal;font-style:normal;"> The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and disclosure of contingent assets and liabilities for the periods indicated in the financial statements. Actual results could differ from those estimates. </span></p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Material estimates that are particularly susceptible to change relate to the determination of the allowance for credit losses, the fair value of share-based compensation, the valuation of deferred tax assets and liabilities, and the fair value of financial instruments. </p> | |
CY2021Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Calibri;text-transform:none;font-variant: normal;">Reclassifications:<span style="font-style:normal;"> </span><span style="font-weight:normal;font-style:normal;">Certain prior-period amounts have been reclassified to conform to the current presentation. Such reclassifications had no impact on previously reported net income or stockholders’ equity. </span></p> | |
CY2021Q1 | rm |
Threshold Period Past Due For Write Off Of Financing Receivables
ThresholdPeriodPastDueForWriteOffOfFinancingReceivables
|
P180D | |
CY2021Q1 | rm |
Bankruptcy Threshold Period Past Due For Write Off Of Financing Receivables
BankruptcyThresholdPeriodPastDueForWriteOffOfFinancingReceivables
|
P60D | |
CY2021Q1 | rm |
Finance Receivables Income Recognition Contractual Delinquent Period
FinanceReceivablesIncomeRecognitionContractualDelinquentPeriod
|
P90D | |
CY2021Q1 | us-gaap |
Financing Receivable Threshold Period Past Due Writeoff
FinancingReceivableThresholdPeriodPastDueWriteoff
|
P90D | |
CY2021Q1 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
1105603000 | |
CY2020Q4 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
1136259000 | |
CY2021Q1 | us-gaap |
Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
|
11800000 | |
CY2020Q4 | us-gaap |
Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
|
12600000 | |
CY2021Q1 | rm |
Number Of Fico Band Categories
NumberOfFICOBandCategories
|
6 | |
CY2021Q1 | us-gaap |
Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
|
217141000 | |
CY2021Q1 | us-gaap |
Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
|
625574000 | |
CY2021Q1 | us-gaap |
Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
|
216738000 | |
CY2021Q1 | us-gaap |
Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
|
35258000 | |
CY2021Q1 | us-gaap |
Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
|
8308000 | |
CY2021Q1 | us-gaap |
Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
|
2584000 | |
CY2021Q1 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
1105603000 | |
CY2021Q1 | us-gaap |
Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
|
47720000 | |
CY2021Q1 | us-gaap |
Financing Receivable Percent Past Due1
FinancingReceivablePercentPastDue1
|
0.043 | |
CY2021Q1 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
1105603000 | |
CY2021Q1 | rm |
Finance Receivable Net Percent
FinanceReceivableNetPercent
|
1.000 | |
CY2021Q1 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
28884000 | |
CY2021Q1 | rm |
Financing Receivable Recorded Investment Nonaccrual Status Percent
FinancingReceivableRecordedInvestmentNonaccrualStatusPercent
|
0.026 | |
CY2020Q4 | us-gaap |
Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
|
60450000 | |
CY2021Q1 | us-gaap |
Interest Receivable
InterestReceivable
|
2400 | |
CY2020Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
150000000 | |
CY2019Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
62200000 | |
CY2020Q1 | rm |
Impact Of Cecl Adoption On Beginning Allowance
ImpactOfCeclAdoptionOnBeginningAllowance
|
60100000 | |
CY2021Q1 | rm |
Covid Reserve Build Release
COVIDReserveBuildRelease
|
-6600000 | |
CY2020Q1 | rm |
Covid Reserve Build Release
COVIDReserveBuildRelease
|
23900000 | |
CY2021Q1 | rm |
Portfolio Growth Reserve Build
PortfolioGrowthReserveBuild
|
-3800000 | |
CY2020Q1 | rm |
Portfolio Growth Reserve Build
PortfolioGrowthReserveBuild
|
-3800000 | |
CY2021Q1 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
139600000 | |
CY2020Q1 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
142400000 | |
CY2021Q1 | rm |
Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
|
0.126 | |
CY2020Q1 | rm |
Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
|
0.129 | |
CY2021Q1 | rm |
Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
|
0.126 | |
CY2020Q1 | rm |
Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
|
0.129 | |
CY2020Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
150000000 | |
CY2021Q1 | us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
11362000 | |
CY2021Q1 | us-gaap |
Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
|
22769000 | |
CY2021Q1 | us-gaap |
Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
|
1007000 | |
CY2021Q1 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
139600000 | |
CY2021Q1 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
1105603000 | |
CY2021Q1 | rm |
Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
|
0.126 | |
CY2019Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
62200000 | |
CY2020Q1 | rm |
Impact Of Cecl Adoption On Beginning Allowance
ImpactOfCeclAdoptionOnBeginningAllowance
|
60100000 | |
CY2020Q1 | us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
49522000 | |
CY2020Q1 | us-gaap |
Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
|
30680000 | |
CY2020Q1 | us-gaap |
Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
|
1258000 | |
CY2020Q1 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
142400000 | |
CY2020Q1 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
1102285000 | |
CY2020Q1 | rm |
Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
|
0.129 | |
CY2021Q1 | rm |
Tdr Number Of Loans Modified
TDRNumberOfLoansModified
|
1412 | |
CY2021Q1 | rm |
Tdr Modified Loans Balance
TDRModifiedLoansBalance
|
4590000 | |
CY2020Q1 | rm |
Tdr Number Of Loans Modified
TDRNumberOfLoansModified
|
3095 | |
CY2020Q1 | rm |
Tdr Modified Loans Balance
TDRModifiedLoansBalance
|
9362000 | |
CY2021Q1 | rm |
Tdr Number Of Defaulted Loans
TDRNumberOfDefaultedLoans
|
428 | |
CY2021Q1 | rm |
Tdr Finance Receivables Defaulted
TDRFinanceReceivablesDefaulted
|
1264000 | |
CY2020Q1 | rm |
Tdr Number Of Defaulted Loans
TDRNumberOfDefaultedLoans
|
2516 | |
CY2020Q1 | rm |
Tdr Finance Receivables Defaulted
TDRFinanceReceivablesDefaulted
|
7325000 | |
CY2021Q1 | us-gaap |
Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
|
600000000.0 | |
CY2021Q1 | us-gaap |
Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
|
600000000 | |
CY2020Q4 | us-gaap |
Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
|
265000 | |
CY2021Q1 | rm |
Derivative Interest Rate Cap Purchases
DerivativeInterestRateCapPurchases
|
602000 | |
CY2020Q1 | rm |
Derivative Interest Rate Cap Purchases
DerivativeInterestRateCapPurchases
|
114000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
|
785000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
|
-29000 | |
CY2021Q1 | us-gaap |
Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
|
1652000 | |
CY2020Q1 | us-gaap |
Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
|
85000 | |
CY2021Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
752200000 | |
CY2021Q1 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
8196000 | |
CY2021Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
744004000 | |
CY2020Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
768909000 | |
CY2020Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
6661000 | |
CY2020Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
762248000 | |
CY2021Q1 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
573110000 | |
CY2020Q4 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
438082000 | |
CY2021Q1 | us-gaap |
Line Of Credit Facility Commitment Fee Description
LineOfCreditFacilityCommitmentFeeDescription
|
The Company pays an unused line fee between 0.375% and 0.65% based upon the average outstanding balance of the facility. | |
CY2020Q4 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
30000000.0 | |
CY2021Q1 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
352000 | |
CY2021Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
11800000 | |
CY2021Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.20 | |
CY2021Q1 | rm |
Provision For Corporate Taxes
ProvisionForCorporateTaxes
|
8348000 | |
CY2020Q1 | rm |
Provision For Corporate Taxes
ProvisionForCorporateTaxes
|
-3577000 | |
CY2021Q1 | us-gaap |
Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
|
-479000 | |
CY2020Q1 | us-gaap |
Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
|
52000 | |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
7869000 | |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-3525000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
25522000 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6325000 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
10543000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
10897000 | |
CY2021Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
523000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
356000 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
11066000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
11253000 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.42 | |
CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.58 | |
CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.31 | |
CY2020Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.56 | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
|
P10Y | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.4783 | |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.4488 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0263 | |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0064 | |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0071 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
908000 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
19.73 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
137000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
30.44 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
137000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
15.44 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
3000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
16.30 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
905000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
22.01 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
11444000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
648000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
20.49 | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
9175000 | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
10.52 | |
CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
7.58 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
2861000 | |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
219000 | |
CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
353000 |